CYCLERION THERAPEUTICS, INC. Increase (Decrease) in Accounts Receivable
CYCLERION THERAPEUTICS, INC. (CYCN) reported Increase (Decrease) in Accounts Receivable of -$1.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-04
- CYCLERION THERAPEUTICS, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $0.00.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$1.00M, a 4100.00% decline year-over-year.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $900.00K, a 61.87% increase year-over-year.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$425.00K.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in accounts receivable for fiscal 2023 was -$96.00K.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in accounts receivable for fiscal 2022 was -$4.00K, a 104.00% decline from fiscal 2021.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in accounts receivable for fiscal 2021 was $100.00K.
- CYCLERION THERAPEUTICS, INC. increase (decrease) in accounts receivable for fiscal 2020 was $0.00.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − S-4/A 3 month · filed 2026-08-04 | -$1.00M 10-Q · filed 2026-08-04 | -$100.00K derived: sum of 3 quarters · filed 2026-08-04 | -$525.00K derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2026-03-31 | -$1.00M S-4/A · filed 2026-07-22 | -$100.00K derived: sum of 2 quarters · filed 2026-07-22 | -$525.00K derived: sum of 3 quarters · filed 2026-07-22 | -$581.00K derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-12-31 | $900.00K derived: S-4/A 12 month − 10-Q 9 month · filed 2026-07-22 | $475.00K derived: sum of 2 quarters · filed 2026-07-22 | $419.00K derived: sum of 3 quarters · filed 2026-08-04 | $444.00K S-4/A · filed 2026-07-22 | ||
| 2025-09-30 | -$425.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$481.00K derived: sum of 2 quarters · filed 2026-08-04 | -$456.00K 10-Q · filed 2025-11-12 | $100.00K derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-06-30 | -$56.00K derived: 10-Q 6 month − S-4/A 3 month · filed 2026-08-04 | -$31.00K 10-Q · filed 2026-08-04 | $525.00K derived: sum of 3 quarters · filed 2026-08-04 | $525.00K derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-03-31 | $25.00K S-4/A · filed 2026-07-22 | $581.00K derived: sum of 2 quarters · filed 2026-07-22 | $581.00K derived: sum of 3 quarters · filed 2026-07-22 | $581.00K derived: sum of 4 quarters · filed 2026-07-22 | ||
| 2024-12-31 | $556.00K derived: S-4/A 12 month − 10-Q 9 month · filed 2026-07-22 | $556.00K derived: sum of 2 quarters · filed 2026-07-22 | $556.00K derived: sum of 3 quarters · filed 2026-07-22 | $556.00K S-4/A · filed 2026-07-22 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $0.00 10-Q · filed 2025-11-12 | $44.00K 10-Q · filed 2024-11-14 | $0.00 derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $0.00 10-Q · filed 2025-08-05 | $0.00 derived: sum of 3 quarters · filed 2025-11-12 | $0.00 derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $0.00 derived: sum of 3 quarters · filed 2025-11-12 | -$96.00K derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2023-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | -$96.00K derived: sum of 3 quarters · filed 2025-11-12 | -$96.00K 10-K/A · filed 2025-11-12 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$96.00K derived: sum of 2 quarters · filed 2024-11-14 | -$96.00K 10-Q · filed 2024-11-14 | -$227.00K derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | -$96.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$96.00K 10-Q · filed 2024-08-07 | -$227.00K derived: sum of 3 quarters · filed 2024-08-07 | -$227.00K derived: sum of 4 quarters · filed 2024-08-07 | ||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-12 | -$131.00K derived: sum of 2 quarters · filed 2024-03-05 | -$131.00K derived: sum of 3 quarters · filed 2024-03-05 | -$131.00K derived: sum of 4 quarters · filed 2024-03-05 | ||
| 2022-12-31 | -$131.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -$131.00K derived: sum of 2 quarters · filed 2024-03-05 | -$131.00K derived: sum of 3 quarters · filed 2024-03-05 | -$4.00K 10-K · filed 2024-03-05 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | $127.00K 10-Q · filed 2023-11-13 | $69.00K derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $127.00K 10-Q · filed 2023-07-28 | $69.00K derived: sum of 3 quarters · filed 2023-07-28 | $227.00K derived: sum of 4 quarters · filed 2023-07-28 | ||
| 2022-03-31 | $127.00K 10-Q · filed 2023-05-12 | $69.00K derived: sum of 2 quarters · filed 2023-05-12 | $227.00K derived: sum of 3 quarters · filed 2023-05-12 | $227.00K derived: sum of 4 quarters · filed 2023-05-12 | ||
| 2021-12-31 | -$58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $100.00K derived: sum of 2 quarters · filed 2023-03-22 | $100.00K derived: sum of 3 quarters · filed 2023-03-22 | $100.00K 10-K · filed 2023-03-22 | -$100.00K 10-K · filed 2022-02-24 | |
| 2021-09-30 | $158.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $158.00K derived: sum of 2 quarters · filed 2022-11-03 | $158.00K 10-Q · filed 2022-11-03 | $158.00K derived: sum of 4 quarters · filed 2022-11-03 | ||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | $0.00 derived: sum of 3 quarters · filed 2022-08-09 | |||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-04 | $0.00 derived: sum of 2 quarters · filed 2022-05-04 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $0.00 10-K · filed 2022-02-24 | ||||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |